HYDERABAD: Officials of Drugs Control Administration, Telangana seized ‘Colinol-SPAS Tablets (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP)’, an allopathic medicine, in Nampally, Hyderabad, for making a misleading advertisement claiming it treats ‘disorders of menstrual flow’.
According to DCA Director-General VB Kamalasan Reddy here on Wednesday, the officials detected a medicine ‘Colinol-SPAS Tablets’ being circulating in the market with misleading claim on its label that it treats ‘disorders of menstrual flow’, which is a contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertisement of certain drugs for treatment of certain diseases and disorders. No person shall take part in publication of advertisement regarding the diseases/disorders indicated under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
During the special raids conducted on 30th April and 1st May, officials from the Drugs Control Administration, Hyderabad Zone, detected ‘Colinol-SPAS Tablets’ (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP) Manufactured and Marketed by: Vivimed Labs Ltd., Plot No. 25, Kundeshwari Village, Kashipur- 244713, Uttarakhand. The label of the product bears a misleading claim stating that it is indicated for the treatment of ‘spasmodic dysmenorrhea, menstrual disorders.’
The advertisement of a medicine for the treatment of ‘disorders of menstrual flow’ is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. P. Santosh, Drugs Inspector, Mehdipatnam and V. Ajay, Drugs Inspector, Goshamahal are among the officers who carried out the raid. Further investigation shall be carried out and action shall be taken as per the law against all the offenders.
The public may report any complaints regarding illegal activities concerning medicines through the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.
%20In%20Drug%20Development){kind=link}